title: Do patients with heart failure benefit from coronary artery bypass grafting?
abstract: OBJECTIVE
  The purpose of this review is to examine the appropriateness of coronary artery bypass grafting (CABG) for the patient with ischemic cardiomyopathy and congestive heart failure.
  
  
  RESULTS
  CABG is the gold standard therapy for patients with advanced multivessel and left main coronary artery disease. A critical analysis of the Surgical Treatment of Ischemic Heart Failure (STICH) trial confirms the benefit of CABG for patients with ischemic cardiomyopathy.
  
  
  CONCLUSIONS
  CABG can be safely applied to patients with heart failure and provides benefit for appropriately selected patients.
authors.affiliation: Division of Cardiac Surgery, Bluhm Cardiovascular Institute, Northwestern Memorial Hospital, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611-2968, USA. emcgee@nmh.org
authors.forename: Edwin C
authors.initials: EC
authors.lastname: McGee
authors.forename: Patrick M
authors.initials: PM
authors.lastname: McCarthy
mesh_terms: D001026:Coronary Artery Bypass; D003324:Coronary Artery Disease / Q000601:surgery*; D006333:Heart Failure / Q000601:surgery*; D006801:Humans; D017202:Myocardial Ischemia / Q000601:surgery*; D009206:Myocardium; D013318:Stroke Volume; D013997:Time Factors; D016896:Treatment Outcome; D016277:Ventricular Function, Left